A Study of SYS6051 in Subjects With Advanced Solid Tumors

NCT07591285 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

114

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: SYS6051

Sponsor

CSPC Megalith Biopharmaceutical Co.,Ltd.